Atlas Trials

A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects

Clinical trial NCT04508179 · COMPLETED

Trial details

NCT number
NCT04508179
Sponsor
7 Hills Pharma, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2020-10-28
Primary completion
2021-10-25
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.